doxorubicin and cisplatin

DRUG2 trials

Sponsors

Ruhr University of Bochum, Imperial College London

Conditions

Chemotherapy EffectGastric CancerPeritoneal Metastases

Phase 2

Intraperitoneal Aerosol Chemotherapy in Gastric Cancer

CompletedNCT01854255

Ruhr University of BochumGastric Cancer

Start: 2013-11-30End: 2016-11-30Updated: 2022-07-08

Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer

Not yet recruitingNCT05318794

Imperial College LondonChemotherapy Effect, Gastric Cancer, Peritoneal Metastases

Start: 2023-11-30End: 2030-07-31Target: 20Updated: 2023-09-13

Related Papers

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study

BMC Cancer2023-10-2417 citations

Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis (PIPAC-GA1).

Journal of Clinical Oncology2017-02-018 citations